Cargando…
Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
RAF kinase inhibitors are clinically active in patients with BRAF (V600E) mutant melanoma. However, rarely do tumors regress completely, with the majority of responses being short-lived. This is partially mediated through the loss of negative feedback loops after MAPK inhibition and reactivation of...
Autores principales: | Saei, Azad, Palafox, Marta, Benoukraf, Touati, Kumari, Nishi, Jaynes, Patrick William, Iyengar, Prasanna Vasudevan, Muñoz-Couselo, Eva, Nuciforo, Paolo, Cortés, Javier, Nötzel, Christopher, Kumarakulasinghe, Nesaretnam Barr, Richard, John Lalith Charles, Bin Adam Isa, Zul Fazreen, Pang, Brendan, Guzman, Marta, Siqin, Zhou, Yang, Henry, Tam, Wai Leong, Serra, Violeta, Eichhorn, Pieter Johan Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028519/ https://www.ncbi.nlm.nih.gov/pubmed/29880484 http://dx.doi.org/10.1084/jem.20171960 |
Ejemplares similares
-
USP26 regulates TGF‐β signaling by deubiquitinating and stabilizing SMAD7
por: Kit Leng Lui, Sarah, et al.
Publicado: (2017) -
USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination
por: Iyengar, Prasanna Vasudevan, et al.
Publicado: (2015) -
A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
por: Sooi, Kenneth, et al.
Publicado: (2023) -
Correspondence on NanoVar’s performance outlined by Jiang T. et al. in “Long-read sequencing settings for efficient structural variation detection based on comprehensive evaluation”
por: Tham, Cheng Yong, et al.
Publicado: (2023) -
Ubiquitination and adaptive responses to BRAF inhibitors in Melanoma
por: Saei, Azad, et al.
Publicado: (2018)